Updates & Member Profiles

Empowering Canada’s Radiopharmaceutical Future: Inside AtomVie’s New Facility

The CNIC team recently visited its member, AtomVie Global Radiopharma’s (AtomVie’s) new Hamilton facility to get a closer look at the company’s next phase of growth. AtomVie is a global leading radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), which emerged as a spinout of the Centre for Probe Development and Commercialization (CPDC), a McMaster University-founded

Read More »

The CNIC team tours Isologic Innovative Radiopharmaceuticals’ facility to see the preparation of life-saving radiopharmaceuticals

On January 12th, the CNIC team had the pleasure of touring the facilities of one of our valued member organizations, Isologic Innovative Radiopharmaceuticals (Isologic), in Burlington, Ontario, for an in-depth look at their radiotracer production processes. Onsite, Frank Maiorino, VP of Commercial and Carlos Fachada, Director of Operations, guided us through their production rooms and

Read More »

CNIC Team Visits Western University and Local Partner Hospitals

The Canadian Nuclear Isotope Council (CNIC) team had the pleasure of visiting Western University, in London, Ontario, to meet with leaders from across the University and local partner hospitals to learn about the innovative work on the production and use of medical isotopes in London. Our visit began at the Verspeeten Family Cancer Centre at

Read More »

Op-ed by James Scongack: When it comes to the global fight against cancer, the world needs more Canada

Canada has been at the forefront of isotope research, development, and production of nuclear medicine technologies for over seven decades. With leading nuclear expertise and achievements, Canada is uniquely situated to inspire isotope innovation, revolutionizing healthcare and leading the global fight against cancer. Globally, Canada is an essential part of the international supply chain for

Read More »

Empowering Canada’s Radiopharmaceutical Future: Inside AtomVie’s New Facility

The CNIC team recently visited its member, AtomVie Global Radiopharma’s (AtomVie’s) new Hamilton facility to get a closer look at the company’s next phase of growth. AtomVie is a global leading radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), which emerged as a spinout of the Centre for Probe Development and Commercialization (CPDC), a McMaster University-founded

Read More »

The CNIC team tours Isologic Innovative Radiopharmaceuticals’ facility to see the preparation of life-saving radiopharmaceuticals

On January 12th, the CNIC team had the pleasure of touring the facilities of one of our valued member organizations, Isologic Innovative Radiopharmaceuticals (Isologic), in Burlington, Ontario, for an in-depth look at their radiotracer production processes. Onsite, Frank Maiorino, VP of Commercial and Carlos Fachada, Director of Operations, guided us through their production rooms and

Read More »

CNIC Team Visits Western University and Local Partner Hospitals

The Canadian Nuclear Isotope Council (CNIC) team had the pleasure of visiting Western University, in London, Ontario, to meet with leaders from across the University and local partner hospitals to learn about the innovative work on the production and use of medical isotopes in London. Our visit began at the Verspeeten Family Cancer Centre at

Read More »

Op-ed by James Scongack: When it comes to the global fight against cancer, the world needs more Canada

Canada has been at the forefront of isotope research, development, and production of nuclear medicine technologies for over seven decades. With leading nuclear expertise and achievements, Canada is uniquely situated to inspire isotope innovation, revolutionizing healthcare and leading the global fight against cancer. Globally, Canada is an essential part of the international supply chain for

Read More »